StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Can you smell it? That's .85

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Jan 13, 2021 12:49pm

120 Views

Post# 32285602

RE:RE:RE:RE:Can you smell it? That's .85

Northerencents wrote: Yep shouldn't be much resistance here up to 1.05

This is very encouraging - looks like investor sentiment has switched to our side. Really, this is a no brainer low risk play - with all the hype on Aristotle and what it represents to the medical community, investors should be clamoring in at these prices.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal